Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Global Payments (GPN) Surges on Earnings Beat and Transformation – What’s Next for This Fintech Powerhouse?

Global Payments (GPN) Surges on Earnings Beat and Transformation – What’s Next for This Fintech Powerhouse?

Company Overview Global Payments Inc. (NYSE: GPN) is a leading worldwide provider of payment technology and software solutions for merchants, issuers, and developers. The company enables businesses to process card, digital and contactless payments, as well as related services like payment security, analytics, and point-of-sale softwaremarkets.ft.combusinessmodelanalyst.com. Headquartered in Atlanta, Georgia, Global Payments has about 27,000 employees in 38 countries and is a member of the Fortune 500 and S&P 500 indicesmarkets.ft.com. Traditionally, Global Payments operated through two segments: Merchant Solutions (payment processing and services for merchants of all sizes) and Issuer Solutions (card issuing and account services for financial institutions).
4 November 2025
·····
Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

Diverging Markets: Tech Strength vs. Blue-Chip Weakness Stock trading to kick off November has been a tale of two markets. High-tech and growth stocks are extending their momentum, while old-line blue chips struggle. On Monday (Nov. 3), the benchmark S&P 500 and Nasdaq Composite managed to close higher – up 0.17% and 0.46%, respectively – even as the Dow Jones Industrial Average fell nearly half a percentreuters.com. This split reflects the radically different fortunes of tech-focused firms versus more traditional industries. What’s driving the divergence? In large part, blockbuster tech news gave the Nasdaq a boost. E-commerce and cloud titan
4 November 2025
····
Hertz Stock Skyrockets on First Profit in 2 Years – What It Means for Investors

Hertz Stock Skyrockets on First Profit in 2 Years – What It Means for Investors

Hertz’s Q3 2025 Comeback: First Profit in Years Fuels Rally Cars parked near a Hertz rental location at New York’s JFK Airport (symbolizing recovering demand). Hertz stunned investors with a return to profitability in Q3 2025, marking a pivotal milestone in its post-bankruptcy turnaround. Hertz Global Holdings’ latest earnings report proved to be a game-changer for the stock. On November 4, 2025, the company announced that it had swung to a net profit for the first time in roughly two years – a stark turnaround from the steep losses logged throughout 2024gurufocus.com. The third-quarter 2025 net income of $184 million
4 November 2025
····
Dave Inc. (DAVE) Stock – Fintech Underdog Turned Wall Street Rocket

Dave Inc. (DAVE) Stock – Fintech Underdog Turned Wall Street Rocket

Current Stock Price & Recent Performance Dave Inc.’s stock has been on a tear in 2025. Shares currently trade around $264 as of November 4, 2025, after spiking nearly 10% on the morning of its earnings releasestockanalysis.com. This jump extended an already strong uptrend – DAVE has rallied over 500% in the past 12 monthsfinviz.com, making it one of the market’s top performers (outperforming ~98.5% of all stocks)chartmill.com. By contrast, the S&P 500 is up only ~18% in the same period. DAVE’s meteoric rise has come after a prolonged slump in 2022–2023; the stock hit a low near $6 (pre-reverse-split)
4 November 2025
·····
Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Company Profile & Background Scienture Holdings, Inc. is a tiny specialty pharmaceutical company focused on developing and commercializing novel formulations that address unmet needs in healthcare Globenewswire Globenewswire. The company’s roots trace back to a 2024 merger with TRxADE Health, a drug marketplace business – after which the combined entity rebranded as Scienture (NASDAQ: SCNX) Nasdaq. In early 2025, management decisively pivoted to pharma: selling off legacy pharmacy/IT subsidiaries for $5 million to free up resources and “dedicate full focus” to its specialty drug pipeline Globenewswire Globenewswire. Today Scienture is headquartered in Tampa, FL (with R&D operations in New York)
4 November 2025
·····
Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next

Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next

A Wild Week for PRLD Stock Prelude Therapeutics – a small precision oncology biotech – suddenly became one of the market’s most volatile stocks in early November 2025. On Monday, Nov 3, PRLD shares skyrocketed, at one point gaining over 150%. The stock surged from roughly $1.60 into the $3–4 range, fueled by speculative buzz and unusually heavy tradingrttnews.com. More than 29 million shares changed hands in a single day (versus an average of ~250,000), and the price hit a 52-week high of $4.19rttnews.com. By the session’s end, Prelude closed near $4 – an astronomical one-day move for a company
4 November 2025
······
Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Current Stock Price & Recent Performance Chart: ONDS daily closing price, Sep–Nov 2025. After a meteoric rise in early October, the stock has retraced to the mid-$6 range. Ondas Holdings’ stock has experienced a roller coaster ride in recent weeks. After trading around $7 in late September, ONDS exploded to a 52-week high near $11.26 by October 8, 2025stockinvest.us. This ~60% surge in a week was accompanied by record volume (over 100 million shares traded on Oct 2) amid breaking news on acquisitions and funding. The rally quickly reversed course: by November 3, ONDS closed at $6.15, down ~45% from
4 November 2025
···
Cipher Mining (CIFR) Rockets on AI Mega-Deals & Bitcoin Boom – What Investors Need to Know

Cipher Mining (CIFR) Rockets on AI Mega-Deals & Bitcoin Boom – What Investors Need to Know

Recent News Highlights (Early November 2025) Cipher Mining has made headlines this week with a flurry of major developments: Company Overview & Business Model Cipher Mining Inc. is a U.S.-based technology company that builds and operates industrial-scale data centers for Bitcoin mining and high-performance computing (HPC) hostinginsidermonkey.com. Formed in 2021 as a spin-off of Dutch mining hardware maker Bitfury, Cipher went public via a SPAC merger (valued around $2 billion at the time)datacenterdynamics.com. Headquartered in New York, the company’s core business has been Bitcoin mining – using powerful computer rigs in large data centers to secure the Bitcoin network in exchange
4 November 2025
····
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Company Overview & History Kenvue Inc. is a leading consumer health company formed from Johnson & Johnson’s storied consumer products division. The name “Kenvue” combines “ken” (knowledge) and “vue” (view), reflecting a vision of insight-driven careen.wikipedia.org. As a spin-off, Kenvue took over J&J’s well-known retail brands, ranging from over-the-counter (OTC) medicines to skincare and baby care. Today its portfolio spans three segmentsinvesting.com: Formally incorporated in 2022, Kenvue began trading on the NYSE (ticker KVUE) in May 2023 after a highly anticipated IPOen.wikipedia.org. The IPO raised $3.8 billion – the largest U.S. listing in nearly two years – and initially valued Kenvue
4 November 2025
····
Bitfarms (BITF) 2025 Stock Surge: Bitcoin Miner’s $500M Windfall & AI Pivot Fuel Rally

Bitfarms (BITF) 2025 Stock Surge: Bitcoin Miner’s $500M Windfall & AI Pivot Fuel Rally

Bottom Line: Bitfarms has rapidly transformed in 2025 from a struggling miner into a well-capitalized player at the forefront of both Bitcoin mining and emerging AI infrastructure. The stock’s dramatic rise mirrors the company’s improved prospects, but future performance will depend on balancing its core crypto business with its new growth ventures. In the near term, all eyes are on the Q3 2025 earnings (due Nov 13) and whether Bitfarms can meet lofty expectations amid Bitcoin’s rally. Longer term, if Bitcoin remains strong and Bitfarms executes its U.S. expansion, the company could transition into a hybrid mining–HPC powerhouse. Investors bullish
4 November 2025
···
Nvidia’s $5 Trillion Milestone: AI Boom Propels NVDA Stock to New Heights

Nvidia’s $5 Trillion Milestone: AI Boom Propels NVDA Stock to New Heights

NVDA Stock Skyrockets on AI Frenzy Nvidia’s stock has been on a meteoric rise, fueled by an unprecedented boom in artificial intelligence. As of November 4, 2025, NVDA trades around $207 per share, up roughly 70–80% year-to-dateeconomictimes.indiatimes.comeconomictimes.indiatimes.com. The stock recently notched all-time highs, propelling Nvidia’s market capitalization above $5 trillion for the first timeeconomictimes.indiatimes.com. This milestone, reached on October 29, 2025, made Nvidia the first publicly traded company ever to cross the $5 trillion markeconomictimes.indiatimes.com – ahead of tech giants like Apple and Microsoft. Shares surged ~3% that day to $206.08 on nearly 190 million shares traded, reflecting fervent investor confidence in Nvidia’s
4 November 2025
·····
Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Stock Price and Recent Performance Year-to-date chart of Evoke Pharma (EVOK) stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement (right end of chart) triggered a dramatic spike to new highs, bringing the stock roughly back to breakeven for the yeartipranks.com. Evoke Pharma’s stock has experienced extreme volatility in recent weeks. After trading in the mid-$4 to $5 range through October, EVOK plunged 10.9% on November 3, 2025 to $4.59 at the closetipranks.com. The very next day, news of the buyout sent the stock exploding upward – EVOK opened around $10.70 on Nov 4
4 November 2025
····
1 … 77 78 79 80 81 … 233

Stock Market Today

SGX share price dips at week’s end after record profit; what investors watch next

SGX share price dips at week’s end after record profit; what investors watch next

7 February 2026
Singapore Exchange shares closed 0.4% lower at S$17.57 on Friday, despite reporting record half-year results and a higher dividend earlier in the week. Broker targets diverged after the update, with Maybank and DBS raising targets while Citi stayed bearish. Investors are watching for signs of momentum from derivatives and equity-market reforms as the next session opens Monday.
South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Go toTop